ShelZuuz t1_j5y0w1d wrote
Reply to comment by Don_Ford in The bivalent mRNA boosters from Pfizer-BioNTech and Moderna were 48% effective against symptomatic infection from the predominant omicron subvariant (XBB/XBB.1.5) in persons aged 18-49 years according to early data published by the CDC by shiruken
So where is the Novavax studies against XBB1.5?
Viewing a single comment thread. View all comments